从化痰活血法论治后循环缺血性眩晕（痰瘀阻窍证）的临床研究

发布时间：2018-04-14 11:23

本文选题：化痰活血法 + 后循环缺血　；参考：《长春中医药大学》2016年硕士论文

【摘要】：目的:观察化痰活血定眩饮治疗后循环缺血性眩晕(痰瘀阻窍证)的临床疗效和安全性。方法:根据入组标准,选取后循环缺血性眩晕(痰瘀阻窍证)病例72例,随机分为治疗组和对照组。治疗组予化痰活血定眩饮,每次100ml,早晚各1次口服;对照组予甲磺酸倍他司汀片6mg,日3次口服。疗程为14天,治疗前后分别进行疗效及安全性观察,并进行统计学分析。结果:分别比较治疗组和对照组治疗前、后眩晕严重程度评分,差异有统计学意义(P0.05);比较治疗组和对照组治疗后眩晕严重程度评分,差异有统计学意义(P0.05)。比较治疗组治疗前、后单项中医证候积分,差异有统计学意义(P0.05);比较治疗组和对照组治疗后单项中医证候积分,差异有统计学意义(P0.05);比较治疗组和对照组中医证候总有效率,差异有统计学意义(P0.05)。分别比较治疗组和对照组治疗前、后TCD指标改善情况,差异有统计学意义(P0.05);比较治疗组和对照组治疗后TCD指标改善情况,差异有统计学意义(P0.05)。两组治疗过程中均未出现不良反应及毒副作用。临床研究表明,治疗组在改善后循环缺血性眩晕患者的眩晕严重程度、中医证候和TCD相关指标方面均优于对照组。结论:以化痰活血法为治疗原则,应用化痰活血定眩饮治疗后循环缺血性眩晕(痰瘀阻窍证)疗效确切,且无不良反应。
[Abstract]:Objective: to observe the clinical efficacy and safety of Huatan Huoxue Dingxuan decoction (Huatan Huoxue Dingxuan decoction) in treating circulatory ischemic vertigo.Methods: 72 cases of posterior circulation ischemic vertigo (phlegm stasis syndrome) were randomly divided into treatment group and control group.The treatment group was treated with Huatan Huoxue Dingxuan decoction (100ml / time) and the control group (6mg / day).The course of treatment was 14 days. The curative effect and safety were observed before and after treatment, and statistical analysis was carried out.Results: the scores of vertigo severity before and after treatment were compared between the treatment group and the control group, the difference was statistically significant (P 0.05), while that of the treatment group and the control group was significantly higher than that of the control group (P 0.05).Before and after treatment, the difference between the treatment group and the control group was statistically significant (P 0.05), the difference between the treatment group and the control group was statistically significant (P 0.05), and the total effective rate of the treatment group and the control group was higher than that of the control group.The difference was statistically significant (P 0.05).The improvement of TCD in treatment group and control group was compared before and after treatment, the difference was statistically significant (P 0.05), and the improvement of TCD index in treatment group and control group was statistically significant (P 0.05).There were no adverse reactions and side effects in both groups.The clinical study showed that the treatment group was superior to the control group in improving the severity of vertigo, TCM syndromes and TCD related indexes in patients with posterior circulatory ischemic vertigo.Conclusion: using Huatan Huoxue Dingxuan decoction as the treatment principle, the therapeutic effect of Huatan Huoxue Dingxuan decoction on circulation ischemic vertigo (phlegm stasis obstruction of orifices) is definite, and there is no adverse reaction.
【学位授予单位】：长春中医药大学
【学位级别】：硕士
【学位授予年份】：2016
【分类号】：R255.3

【参考文献】